I'm sorry if this is dragging up an old point, I've only recently been going through this thread for the comments I have missed. The concept of 20+ autoantibodies being present within the entire potentially autoimmune based ME cohort is something that sounds very interesting and is something I doubt many people have ever considered.
From my reading around the subject it seems clear that there is a definite 'neurological' dysfunction in ME patients and the most common term I see when reading articles around this subject are autonomic dysfunction (which, while an interesting topic is something of an overly broad term) and HPA axis dysfunction (hypothalamic-pituitary-adrenal axis). I admit that much of the discussion regarding this is somewhat beyond me (although I intend to read up on the subject at some point) however it seems an interesting concept, especially given that there could be thousands of unique targets within the hypothalamus and pituitary gland. I'll be interested to see whether the study investigating possible hypothalamus targeted antibodies comes up with anything.
Such dysfunction could go some way to explain the vast array of symptoms patients experience and also the seemingly vast spectrum of morbidity between patients, with some completely bed bound while others are able to struggle on, working full-time. It could also explain why generic test such as blood counts, ESR and CRP are very often normal in patients despite high levels of disability.
That aside, I do have a query regarding the rituximab trial. Are you also recording patients self reported symptoms alongside results from the pre-trial study? It would be interesting to see whether certain symptoms such as swollen lymph nodes, headaches, tremors etc are more or less frequent in a possible responding group - although I doubt this will prove a significant difference I would expect some symptoms to appear more frequently in those who respond. Acute/gradual onset could also have a huge difference although i'm certain these are things you've already considered. I was reading a paper recently exploring how cytokine fluctuations in Lupus appear to correlate to differing symptom complexes (
http://www.ncbi.nlm.nih.gov/pubmed/8445045). It's interesting to see the variation that exists even within a fairly well defined disease such as lupus. If ME did truly have numerous different causative autoantibodies perhaps the degree of variation within ME would be even greater.